Showing 1561-1570 of 2494 results for "".
- Clearside Biomedical Announces Multiple Oral Presentations to be Given at the ASRS Annual Meetinghttps://modernod.com/news/clearside-biomedical-announces-multiple-oral-presentations-to-be-given-at-the-asrs-annual-meeting/2476742/Clearside Biomedical announced that multiple oral presentations on Clearside’s pipeline and proprietary SCS Microinjector targeting the suprachoroidal space will be given at the upcoming American Society of Retinal Specialists (ASRS) annual meeting taking place July 26-30, 2019 in Chicago. <
- Here Are 6 Factors to Consider When Reopening Practiceshttps://modernod.com/news/here-are-6-factors-to-consider-when-reopening-practices/2477841/As thousands of physicians are working to get their practices up and running again many are thinking about safety measures to keep patients and employees safe. But what about potential medical malpractice risks and privacy protocols? As stay-at-home restrictions are relaxed, physician practices a
- The Vision Council Announces Dates for the 2021 Virtual Executive Summit: January 26–28, 2021https://modernod.com/news/the-vision-council-announces-dates-for-the-2021-virtual-executive-summit-january-26-28-2021/2478440/The Vision Council today announces that the
- More than 240 Exhibitors Commit to Vision Expo East 2022, Taking Place In-Person from March 31–April 3 at the Javits Centerhttps://modernod.com/news/more-than-240-exhibitors-commit-to-vision-expo-east-2022-taking-place-in-person-from-march-31-april-3-at-the-javits-center/2480582/The organizers of Vision Expo, The Vision Council and RX, share that more than 240 exhibitors have committed to Vision Expo East to-date. Vision Expo East 2022 will take place from March 31–April 3 at the Jacob Javits Center in New York City. &l
- EyePoint Pharmaceuticals Reports Positive 30-Day Safety Results for All Cohorts From DAVIO Trial of EYP-1901 for Wet AMDhttps://modernod.com/news/eyepoint-pharmaceuticals-reports-positive-30-day-safety-results-for-all-cohorts-from-the-davio-trial-of-eyp-1901-for-wet-amd/2479344/EyePoint Pharmaceuticals announced positive safety results from its phase 1 clinical trial of EYP-1901, a potential twice-yearly sustained delivery anti-VEGF treatment targeting wet age-related macular degeneration (AMD). All dose cohorts have reached at least 30-day post-dosing foll
- Vision Expo West 2020 Cancelled; Virtual Offerings Plannedhttps://modernod.com/news/vision-expo-west-2020-cancelled-new-virtual-offerings-planned/2477995/The Vision Council and Reed Exhibitions, organizers of Vision Expo, announced the decision to cancel Vision Expo West 2020, scheduled to take place in Las Vegas from September 23-26. “Over the past several months, Reed Exhibitions’ Vision Expo team and The Vision Council worked toget
- Vision Expo East Cancelled Due to Coronavirus; Will Consolidate With Vision Expo West in Las Vegashttps://modernod.com/news/vision-expo-east-cancelled-due-to-coronavirus-will-consolidate-with-vision-expo-west-in-las-vegas/2477359/The organizers of Vision Expo announced that they are cancelling the scheduled Vision Expo East meeting scheduled to take place in New York, March 26-29, and consolidate that meeting with Vision Expo West in Las Vegas, Sept. 23-26. The decision was made due to concerns over the spread of the coro
- When Coronavirus Vaccines Are Ready, Dentists, Optometrists May Give Shotshttps://modernod.com/news/when-coronavirus-vaccines-are-ready-dentists-optometrists-may-give-shots/2478599/With multiple COVID-19 vaccines rapidly heading toward approval, optometrists and dentists are pushing for the authority to immunize patients during routine eye exams and dental cleanings. These medical professionals say their help will be needed to distribute the vaccines
- Dry Eye Institute Launches 'DEI On Demand' and Kicks Off Inaugural Road Eventhttps://modernod.com/news/dry-eye-institute-launches-dei-on-demand-and-kicks-off-inaugural-road-event/2482605/The Dry Eye Institute (DEI), an educational program for optometrists and ophthalmologists specializing in advanced dry eye care, has announced that for the first time, the institute’s curriculum is now available online through 'DEI On Demand.' DEI also announced that
- AstraZeneca Kicks Off Phase 3 Study of COVID-19 Vaccine AZD1222 in the UShttps://modernod.com/news/astrazeneca-kicks-off-phase-3-study-of-covid-19-vaccine-azd1222-in-the-us/2478229/AstraZeneca announced the start of a phase 3 study in the US investigating its experimental COVID-19 vaccine AZD1222 in up to 30,000 adults aged 18 years or over. Subjects in the trial, called D8110C00001, will be randomized to receive two doses of either AZD1222 or a saline control, 4 weeks apar